Clinical pharmacists’ interventions in a German University Hospital
- 629 Downloads
Objective To evaluate pharmaceutical interventions by ward-based clinical pharmacists in Germany. Setting Two ward-based clinical pharmacists working at the Departments of Stem Cell Transplantation and Intensive Care Medicine. Methods Pharmaceutical interventions during ward rounds from December 1st 2006 to November 30th 2008 were recorded and classified according to our own system that was adopted from established classification systems. Main outcome measure Classification of (1) cause of intervention, (2) intervention, (3) outcome of intervention and (4) initiator of intervention. Results Altogether 2,312 interventions were documented. Besides 520 cases of information about drugs (rational selection, occurrence of infrequent adverse events or interactions), the main interventions were recommendations for the addition, the withdrawal or the replacement of a drug (n = 907, 50.6%) and advices for the change of dosage, dosing intervals or dose adjustment according to impaired renal or liver function (n = 584, 32.6%). The vast majority of the suggested interventions (92.8%) have been accepted. Conclusion The participation of a clinical pharmacist during ward rounds contributes to the optimisation of pharmacotherapy, in terms of choosing the most appropriate drug and/or the suitable dosage and may improve patient care.
KeywordsClassification Clinical pharmacist Germany Hospital pharmacy Pharmaceutical intervention Pharmacotherapy
We want to thank Prof. Dr. med. Georg Kreymann, Prof. Dr. med. Axel R. Zander and Dr. Michael Baehr, who initiated the project “Clinical Pharmacists” at our hospital for the fruitful cooperation at all times.
There was no external funding obtained for this work.
Conflicts of interest
There are no conflicts of interest to be stated.
- 1.Surugue J, Vulto AG. Workforce of EU hospitals and pharmacy services: a direct patient safety issue. EJHP Pract. 2006;12:31–3.Google Scholar
- 10.Heyde C, Rutsch A, Eschke D. Clinical pharmacists increase the safety of drug therapy at the time of admission. Krankenhauspharmazie. 2009;30:215–7.Google Scholar
- 11.Walk SU, Fritz S, Pruszydlo MG, Hartwig W, Haefeli WE, Hoppe-Tichy T. Pharmaceutical counselling of drug switches at the interface between primary and tertiary care. Krankenhauspharmazie. 2009;30:218–21.Google Scholar
- 12.Frey OR. Therapeutic drug monitoring. Krankenhauspharmazie. 2009;30:222–4.Google Scholar
- 13.Hartmann A, Eberhardt T, Brüggmann J. Dose individualization in patients with renal insufficiency. Krankenhauspharmazie. 2009;30:225–9.Google Scholar
- 14.Krämer I. Pharmacist-conducted patient education and compliance enhancement in specific patient groups. Krankenhauspharmazie. 2009;30:230–5.Google Scholar
- 15.Sattler A. Pharmaceutical care with SOAP-notes. Krankenhauspharmazie. 2009;30:239–41.Google Scholar
- 16.Probst W. Benefit of pharmaceutical care in patients feeded via enteral tube. Krankenhauspharmazie. 2009;30:248–50.Google Scholar
- 17.Neubauer W, Hug MJ, Bertz H, Strehl E, Engelhardt M. The role of the pharmacist in the development of clinical guidelines. Krankenhauspharmazie. 2009;30:255–8.Google Scholar
- 19.Langebrake C, Hilgarth H. Clinical pharmacy at the University Medical Centre Hamburg-Eppendorf. Krankenhauspharmazie. 2008;29:83–9.Google Scholar
- 20.Pharmaceutical Care Network Europe. PCNE classification for drug-related problems V5.01. 2008. http://www.pcne.org/. Accessed 30 Jul 2008.
- 32.Kantelhardt P, Langebrake C. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part I medication errors). Krankenhauspharmazie. 2009;30:63–8.Google Scholar
- 33.Langebrake C, Kantelhardt P. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part II interventions). Krankenhauspharmazie. 2009;30:149–55.Google Scholar